Cutaneous leishmaniasis in the Sudan.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000965:Antimony / Q000627:therapeutic use; D005260:Female; D005455:Fluorescent Antibody Technique; D005942:Gluconates / Q000627:therapeutic use; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007891:Leishmania / Q000302:isolation & purification; D007896:Leishmaniasis / Q000188:drug therapy / Q000453:epidemiology*; D008297:Male; D008875:Middle Aged; D012882:Skin Tests; D013397:Sudan
D005942:Gluconates; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D000965:Antimony